On March 11, the FDA approved the FC2, a new, less expensive version of the previously approved female condom (FC1).

In spite of stigma surrounding this method, the International Women's Health Coalition has noted a great deal of demand for female condoms in their experiences working to prevent the spread of HIV/AIDS, particularly in Africa, as outlined in their recent video "Female Condoms: Demand and Distribution." According to the video, a primary deterrent for use of the female condom in Africa has been its cost and, in part as a result of cost, lack of availability.

Considering that the female condom is currently the only form of contraception designed for use by women that protects against both unintended pregnancy and HIV infection, making it more financially accessible is certainly a step in the right direction. Here's hoping governments and health advocates in the U.S. and abroad can leverage this development to provide women and couples with more options to protect themselves against infection and unintended pregnancy.